These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 31450226

  • 21. Decursin inhibits retinal neovascularization via suppression of VEGFR-2 activation.
    Kim JH, Kim JH, Lee YM, Ahn EM, Kim KW, Yu YS.
    Mol Vis; 2009 Sep 12; 15():1868-75. PubMed ID: 19756180
    [Abstract] [Full Text] [Related]

  • 22. Inhibition of pathological retinal angiogenesis by the integrin αvβ3 antagonist tetraiodothyroacetic acid (tetrac).
    Yoshida T, Gong J, Xu Z, Wei Y, Duh EJ.
    Exp Eye Res; 2012 Jan 12; 94(1):41-8. PubMed ID: 22123068
    [Abstract] [Full Text] [Related]

  • 23. Anti-angiogenic activity and mechanism of kaurane diterpenoids from Wedelia chinensis.
    Huang W, Liang Y, Wang J, Li G, Wang G, Li Y, Chung HY.
    Phytomedicine; 2016 Mar 15; 23(3):283-92. PubMed ID: 26969382
    [Abstract] [Full Text] [Related]

  • 24. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
    Huang SW, Lien JC, Kuo SC, Huang TF.
    Carcinogenesis; 2012 May 15; 33(5):1022-30. PubMed ID: 22436611
    [Abstract] [Full Text] [Related]

  • 25. Ruboxistaurin, a PKCbeta inhibitor, inhibits retinal neovascularization via suppression of phosphorylation of ERK1/2 and Akt.
    Nakamura S, Chikaraishi Y, Tsuruma K, Shimazawa M, Hara H.
    Exp Eye Res; 2010 Jan 15; 90(1):137-45. PubMed ID: 19825373
    [Abstract] [Full Text] [Related]

  • 26. Salinomycin exerts anti-angiogenic and anti-tumorigenic activities by inhibiting vascular endothelial growth factor receptor 2-mediated angiogenesis.
    Li T, Liu X, Shen Q, Yang W, Huo Z, Liu Q, Jiao H, Chen J.
    Oncotarget; 2016 May 03; 7(18):26580-92. PubMed ID: 27058891
    [Abstract] [Full Text] [Related]

  • 27. Anti-angiogenic effect of KH902 on retinal neovascularization.
    Wang F, Bai Y, Yu W, Han N, Huang L, Zhao M, Zhou A, Zhao M, Li X.
    Graefes Arch Clin Exp Ophthalmol; 2013 Sep 03; 251(9):2131-9. PubMed ID: 23740520
    [Abstract] [Full Text] [Related]

  • 28. The anti-angiogenic action of 2-deoxyglucose involves attenuation of VEGFR2 signaling and MMP-2 expression in HUVECs.
    Chuang IC, Yang CM, Song TY, Yang NC, Hu ML.
    Life Sci; 2015 Oct 15; 139():52-61. PubMed ID: 26285173
    [Abstract] [Full Text] [Related]

  • 29. A novel 2-aminobenzimidazole-based compound Jzu 17 exhibits anti-angiogenesis effects by targeting VEGFR-2 signalling.
    Lien JC, Chung CL, Huang TF, Chang TC, Chen KC, Gao GY, Hsu MJ, Huang SW.
    Br J Pharmacol; 2019 Oct 15; 176(20):4034-4049. PubMed ID: 31368127
    [Abstract] [Full Text] [Related]

  • 30. Salinomycin exhibits anti-angiogenic activity against human glioma in vitro and in vivo by suppressing the VEGF-VEGFR2-AKT/FAK signaling axis.
    Bi YL, Mi PY, Zhao SJ, Pan HM, Li HJ, Liu F, Shao LR, Zhang HF, Zhang P, Jiang SL.
    Int J Mol Med; 2017 May 15; 39(5):1255-1261. PubMed ID: 28358414
    [Abstract] [Full Text] [Related]

  • 31. Eriocalyxin B, a natural diterpenoid, inhibited VEGF-induced angiogenesis and diminished angiogenesis-dependent breast tumor growth by suppressing VEGFR-2 signaling.
    Zhou X, Yue GG, Liu M, Zuo Z, Lee JK, Li M, Tsui SK, Fung KP, Sun H, Pu J, Lau CB.
    Oncotarget; 2016 Dec 13; 7(50):82820-82835. PubMed ID: 27756875
    [Abstract] [Full Text] [Related]

  • 32. Therapeutic efficacy of a novel non-peptide αvβ3 integrin antagonist for pathological retinal angiogenesis in mice.
    Li YJ, Li XH, Wang LF, Kuang X, Hang ZX, Deng Y, Du JR.
    Exp Eye Res; 2014 Dec 13; 129():119-26. PubMed ID: 25446322
    [Abstract] [Full Text] [Related]

  • 33. Carvedilol may attenuate liver cirrhosis by inhibiting angiogenesis through the VEGF-Src-ERK signaling pathway.
    Ding Q, Tian XG, Li Y, Wang QZ, Zhang CQ.
    World J Gastroenterol; 2015 Aug 28; 21(32):9566-76. PubMed ID: 26327764
    [Abstract] [Full Text] [Related]

  • 34. Antrodia cinnamomea produces anti-angiogenic effects by inhibiting the VEGFR2 signaling pathway.
    Huang TT, Lan YW, Ko YF, Chen CM, Lai HC, Ojcius DM, Martel J, Young JD, Chong KY.
    J Ethnopharmacol; 2018 Jun 28; 220():239-249. PubMed ID: 29609012
    [Abstract] [Full Text] [Related]

  • 35. An andrographolide derivative AGP-26b exhibiting anti-angiogenic activity in HUVECs and zebrafish via blocking the VEGFA/VEGFR2 signaling pathway.
    Huang B, Peng Y, Li J, Li S, Sun Y, Wang D, Yang B, Chan JY, Yu H, Leung GP, Hoi MP, Zhou GC, Lee SM.
    Mol Biosyst; 2017 Feb 28; 13(3):525-536. PubMed ID: 28098292
    [Abstract] [Full Text] [Related]

  • 36. Oridonin exhibits anti-angiogenic activity in human umbilical vein endothelial cells by inhibiting VEGF-induced VEGFR-2 signaling pathway.
    Jiang JH, Pi J, Cai JY.
    Pathol Res Pract; 2020 Aug 28; 216(8):153031. PubMed ID: 32703495
    [Abstract] [Full Text] [Related]

  • 37. Acrizanib as a Novel Therapeutic Agent for Fundus Neovascularization via Inhibitory Phosphorylation of VEGFR2.
    Tang X, Cui K, Wu P, Hu A, Fan M, Lu X, Yang F, Lin J, Yu S, Xu Y, Liang X.
    Transl Vis Sci Technol; 2024 Jan 02; 13(1):1. PubMed ID: 38165719
    [Abstract] [Full Text] [Related]

  • 38. Novel Peptide NT/K-CFY Derived from Kringle Structure of Neurotrypsin Inhibits Neovascularization.
    Yao X, Chen C, Zhang J, Xu Y, Xiong S, Gu Q, Xu X, Suo Y.
    Curr Eye Res; 2021 Oct 02; 46(10):1551-1558. PubMed ID: 33870816
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.